Cardiovascular Diseases Research in Texas
Cardiovascular Diseases Research (93.837) awarded $635 million to recipients in Texas in 546 grants from fiscal 2021 to 2025, 4.3% of the program's national total. The University of Texas Southwestern Medical Center received the most, $150 million.
- Awarded in Texas$635 million
- Awards546
- Share of the program4.3%
- Rank among states7th of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 252 | $120 million |
| FY 2022 | 262 | $123 million |
| FY 2023 | 256 | $126 million |
| FY 2024 | 265 | $126 million |
| FY 2025 | 270 | $141 million |
Recipients in Texas
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The University of Texas Southwestern Medical Center | Colleges and universities | 117 | $150 million |
| Baylor College of Medicine | Colleges and universities | 121 | $127 million |
| University of Texas Health Science Center at Houston | Colleges and universities | 48 | $63.0 million |
| The University of Texas Health Science Center at San Antonio | Colleges and universities | 18 | $47.0 million |
| The Univeristy of Texas M.D. Anderson Cancer Center | Colleges and universities | 21 | $31.4 million |
| University of Texas at Austin | Colleges and universities | 32 | $28.7 million |
| Texas a & M University System Health Science Center | Colleges and universities | 23 | $22.3 million |
| The Methodist Hospital Research Institute | Nonprofits | 17 | $21.3 million |
| University of Houston System | Colleges and universities | 15 | $19.4 million |
| The University of Texas Health Science Center at Tyler | Colleges and universities | 16 | $16.5 million |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 82 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to Texas?
$635 million from fiscal 2021 to 2025, across 546 awards. Texas ranks 7th of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in Texas?
The largest recipient is The University of Texas Southwestern Medical Center, with $150 million in 117 awards. Next are Baylor College of Medicine and University of Texas Health Science Center at Houston.
Can organizations in Texas apply now?
Yes, 82 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in Texas
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Unaccompanied Alien Children Program
- Special Education Grants to States
- Community Development Block Grants/State's program and Non-Entitlement Grants in Hawaii